Salvation of the diabetic foot through a comprehensive individualized treatment of the patient with type 2 diabetes: case study
Authors:
Ivana Flanderová
Authors‘ workplace:
Diabetologické centrum II. interní kliniky LF UK v Plzni a FN Plzeň
Published in:
Vnitř Lék 2017; 63(5): 343-347
Category:
Case Reports
Overview
This is a case of men with type 2 diabetes mellitus and diabetic foot. The patient was in danger of limb amputation. After improvement of diabetes, hypertension and dyslipidemia therapies a comprehensive treatment of diabetic foot including angioplasty, antibiotics and local maggot therapy was used for diabetic foot management. Therapy result was very satisfying for the patient. Despite of amputation of the 2nd digit due to advanced gangrene, the whole foot function was saved.
Key words:
diabetes foot – maggot therapies – type 2 diabetes mellitus
Sources
1. Škrha J, Pelikánová T, Kvapil M. Doporučený postup péče o diabetes mellitus 2. typu. ČDS 2016. Dostupné z WWW: <http://www.diab.cz/dokumenty/standard_lecba_dm_typ_II.pdf>.
2. Bailey CJ, Del Prato S, Eddy D et al. Earlier intervention in type 2 diabetes the case for achieving early and sustained glycaemic control. Int J Clin Pract 2005; 59(11): 1309–1316.
3. Filipovský J, Widimský J Jr, Ceral J et al. Diagnostické a léčebné postupy u arteriální hypertenze – verze 2012. Doporučení České společnosti pro hypertenzi. Vnitř Lék 2012; 58(10): 785–801.
4. Keech AC, Simek RJ, Barter P et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005; 366(9500): 1849–1861.
5. Ginsberg HN, Elam MB, Lovato LC et al. [ACCORD Study Group]. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010; 362(17): 1563–1574. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1001282>.
6. Catapano AL, Graham I, De Backer G et al. [Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)]. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 2016; 37(39): 2999–3058. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehw272>.
7. Jirkovská A. Syndrom diabetické nohy z pohledu internisty podiatra. Vnitř Lék 2016; 7–8(Suppl 4): S42-S47.
8. Jirkovská A. Možnosti plnění mezinárodních doporučení terapie syndromu diabetické nohy v České republice. Vnitř Lék 2011; 57(11): 908–912.
9. Jirkovská A, Lacigová S, Rušavý Z et al. Doporučený postup pro prevenci, diagnostiku a terapii syndromu diabetické nohy. Česká diabetologická společnost ČLS JEP. 10.10.2016. Dostupné z WWW: <http://www.diab.cz/dokumenty/standard_diab_noha.pdf>.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2017 Issue 5
Most read in this issue
- Acute lymphoblastic leukemia of adults – a case of prolonged hip pain diagnostics with a surprising conclusion: case report
- Osteoprotective therapy with bisphosphonates or denosumab in patients with multiple myeloma: benefit and risks
- Thoughts about valvular abnormalities yesterday and today
- Is it intestinal tuberculosis again? Case report